PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dr. Michael Stosich, Grayslake Orthodontist Shares Reasons for a Second Opinion

There are some instances when a patient or parent of a patient will want to get a second orthodontic treatment opinion. Dr. Michael Stosich explains some of them.

2013-03-12
GRAYSLAKE, IL, March 12, 2013 (Press-News.org) Orthodontic treatment typically carries a significant price tag. For that reason, patients or parents of patients ought to feel confident in their choice of orthodontist, as well as the treatment plan.

When in doubt, get a second opinion.

Dr. Michael Stosich, an orthodontist in Grayslake who owns iDentity Orthodontics, frequently receives calls from people seeking a second opinion on treatment recommendations from another provider.

Stosich recommends getting a second opinion in these situations:

1- An orthodontist recommends emergency treatment.

"The need for emergency treatment is rare," Stosich says. "If you're being pressured to start treatment straight away, get another opinion."

2- An orthodontist recommends jaw surgery or tooth extraction.

"Surgery and extractions are serious decisions," says the Grayslake orthodontics expert. "Even if that's the proper course of action, I recommend getting another opinion just for peace of mind."

3- Lack of rapport between the patient and/or parent and the orthodontist.

Getting braces or some other form of orthodontic treatment requires a time commitment. A relationship will develop between the patient, parents and orthodontist. If a patient or parent doesn't "click" with the orthodontist, this could be a good sign to shop around.

"Find someone you like, and in whom you have confidence regarding their approach, experience and abilities," says Grayslake orthodontist, Stosich.

A Final Thought
Selecting a provider should be done with serious thought. Ask questions. Look at before/after photos of patients with similar malocclusions the orthodontist has treated.

Stosich's goal is to continuously provide effective treatment in an atmosphere that sets patients and parents at ease, and generates excitement toward their treatment, he says. Those who experience anything other than comfort and confidence in the orthodontist's skill and expertise should search until they find a professional with whom they can be happy.

Learn More:
To learn more about Dr. Michael Stosich or to schedule a complimentary consultation, call (847) 548-4200.

About Dr. Michael Stosich
Dr. Michael Stosich attended the Temple University School of Dentistry in Philadelphia and earned a Doctor of Dental Medicine degree. He then pursued critical specialty training in orthodontics and dentofacial orthopedics at Temple University, and also received a Master's Degree. He was awarded the Coben Scholar in Orthodontics. He went on to complete a four-year craniofacial fellowship at the University of Pennsylvania and The Children's Hospital of Philadelphia.

2013 Sinai Marketing and Dr. Michael Stosich. Authorization to post is granted, with the stipulation that Sinai Marketing and Dr. Michael Stosich are credited as sole source. Linking to other sites from this article is strictly prohibited, with the exception of herein imbedded links.

iDentity Orthodontics offers orthodontic care such as invisalign, adult braces and other orthodontic services in Illinois.


ELSE PRESS RELEASES FROM THIS DATE:

MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal Agencies

2013-03-12
MobileSmith, a leading provider of mobile software solutions for enterprise customers, and TVAR Solutions, a value-added reseller of cloud and mobile infrastructure to the US government, announced a strategic partnership to deliver innovative mobile solutions to Federal agencies. "With TVAR's 20 years of experience delivering cloud IT solutions to the government, MobileSmith can now empower more Federal clients to quickly and cost-effectively build, deploy, and manage secure mobile applications for both iOS and Android devices," said Bob Dieterle, Senior VP ...

CyberlinkASP Completes SSAE 16 SOC 1 Audit Across Datacenter Footprint

2013-03-12
CyberlinkASP, the leader in hosted virtual desktop and private cloud solutions, today announced the completion of the company's annual SSAE 16 SOC 1 audit. CyberlinkASP enlisted an outside accounting firm and subjected itself to a rigorous third party review of all infrastructure, personnel, policies and procedures across its Dallas, Chicago and London facilities. "This has been a major initiative for us the past few years as more and more firms require documented security policies and procedures relating to IT. We feel it's a must for anyone hosting or managing ...

Laura Wellington: "The Four-Star Diet" Sells Out on Amazon Leading to Invitations From "All-Star" Talk Shows

2013-03-12
No doubt, the media tour for the author of "The Four-Star Diet: Based Upon The Wisdom Of General Colin Powell & Other Ridiculously Brilliant Leaders" has only just begun. Explosive sales on Amazon and similar retailers have made it nearly impossible to get your hands on a print version of the book. With the demand continuing to rise to an already "sell out" crowd, Author Laura J. Wellington has received invitations to appear on numerous "Celebrity, Style, and News" shows from as far away as the UAE. She will begin to make those appearances ...

Rush scientists identify buphenyl as a possible drug for Alzheimer's disease

2013-03-11
(CHICAGO) – Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease. Hyperammonemia is a life-threatening condition that can affect patients at any age. It is caused by abnormal, high levels of ammonia in the blood. Studies in mice with Alzheimer's disease (AD) have shown that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth and protects learning and memory, according to neurological researchers at the Rush University Medical Center. Results from ...

Shock teams and ECMO save lives in massive STEMI

2013-03-11
MINNEAPOLIS, MN - March 9, 2013 - The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the American College of Cardiology Scientific Sessions. ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia (TH) use within a STEMI Network. "For many patients who present with ...

Niacin therapy shows no benefits, has some harmful effects

2013-03-11
SAN FRANCISCO (March 9, 2013) — A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Detailed trial data is presented here for the first time. Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) is the largest-ever study of niacin, commonly used to raise ...

Drug protects against kidney injury from imaging dye in ACS patients

2013-03-11
SAN FRANCISCO (March 10, 2013) —High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests. Previous studies have demonstrated the kidney-protective value of various statins administered before patients undergo ...

Encouraging early results for redesigned Sapien valve

2013-03-11
SAN FRANCISCO (March 10, 2013) — The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session. PARTNER II is the first randomized clinical trial involving the Sapien XT valve and the only one that compares the new device to the original FDA-approved Sapien ...

New biolimus stent equal to everolimus stent at 1 year

2013-03-11
SAN FRANCISCO (March 10, 2013) — In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented today at the American College of Cardiology's 62nd Annual Scientific Session. Drug-eluting stents are structures placed inside narrowed coronary arteries to restore proper blood flow. A polymer coating on these devices slowly releases a drug designed to prevent restenosis—another blockage at the same site—and prevent a second ...

Fewer adverse events with 'double kissing' crush stent than culotte

2013-03-11
SAN FRANCISCO (March 10, 2013) — Patients with a type of coronary lesion linked with poor prognosis fared significantly better with the stent technique known as double kissing crush than with culotte stenting, according to data from the DKCRUSH-III trial presented today at the American College of Cardiology's 62nd Annual Scientific Session. DKCRUSH-III is the first head-to-head comparison of double kissing (DK) crush and culotte stent techniques in coronary artery disease. The study focused on bifurcation lesions, which involve a main branch and a smaller side branch ...

LAST 30 PRESS RELEASES:

Quandela, the CNRS, Université Paris-Saclay and Université Paris Cité join forces to accelerate research and innovation in quantum photonics

Pulmonary vein isolation with optimized linear ablation vs pulmonary vein isolation alone for persistent AF

New study finds prognostic value of coronary calcium scores effective in predicting risk of heart attack and overall mortality in both women and men

New fossil reveals the evolution of flying reptiles

Redefining net zero will not stop global warming – scientists say

Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health

Tiny worm makes for big evolutionary discovery

Cause of the yo-yo effect deciphered

Suicide rates for young male cancer survivors triple in recent years

Achalasia and esophageal cancer: A case report and literature review

Authoritative review makes connections between electron density topology, future of materials modeling and how we understand mechanisms of phenomena in familiar devices at the atomistic level

Understanding neonatal infectious diseases in low- and middle-income countries: New insights from a 30-year study

This year’s dazzling aurora produced a spectacular display… of citizen science

New oral drug to calm abdominal pain

New framework champions equity in AI for health care

We finally know where black holes get their magnetic fields: Their parents

Multiple sclerosis drug may help with poor working memory

The MIT Press releases workshop report on the future of open access publishing and policy

Why substitute sugar with maple syrup?

New study investigates insecticide contamination in Minnesota’s water

The Einstein Foundation Berlin awards €500,000 prize to advance research quality

Mitochondrial encephalopathy caused by a new biallelic repeat expansion

Nanoplastics can impair the effect of antibiotics

Be humble: Pitt studies reveal how to increase perceived trustworthiness of scientists

Promising daily tablet increases growth in children with dwarfism

How 70% of the Mediterranean Sea was lost 5.5 million years ago

Keeping the lights on and the pantry stocked: Ensuring water for energy and food production

Parkinson’s Paradox: When more dopamine means more tremor

Study identifies strategy for AI cost-efficiency in health care settings

NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release

[Press-News.org] Dr. Michael Stosich, Grayslake Orthodontist Shares Reasons for a Second Opinion
There are some instances when a patient or parent of a patient will want to get a second orthodontic treatment opinion. Dr. Michael Stosich explains some of them.